Lannett Eyes Another $11m In Savings With R&D Sea Change, Job Cuts

Company Plans To Shutter Two More Facilities In PA As Surgery Continues

Lannett unveiled another round of cost-saving initiatives alongside its financial Q2 earnings, including plans for a radical change for its R&D development.

Struggling Lannett has shed light on further operational and financial restructuring, including another cost saving plan that will shed dozens of jobs, as well as a reverse-stock split intended to bring the company into compliance for listing on the New York Stock Exchange.

The Philadelphia-based firm’s latest strategy involves all but giving up on internal pipeline development in favor of a partnered approach...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business